Neoadjuvant Chemotherapy: Mortality in Low- vs High-Volume Centers

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Alex Melamed to discuss Neoadjuvant Chemotherapy: Mortality in Low- vs High-Volume Centers.

Alex Melamed, MD, MPH, is a gynecologic oncologist and clinical outcomes researcher in the Department of Obstetrics and Gynecology at Mass General Hospital and an Associate Professor at Harvard Medical School. He co-directs the Inference Lab in MGH's Vincent Department of Obstetrics and Gynecology. Dr. Melamed's research focuses on applying methods that provide meaningful insights from observational data. In particular, his work explores how focusing on temporal and spatial variation in clinical practice can help to uncover how health care affects patient outcomes. Some of his research focuses on increasing understanding of how surgical care affects the lives of cancer patients. Dr. Melamed is an associate editor of the International Journal of Gynecological Cancer.